Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk
- 20 March 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 115 (11) , 1371-1375
- https://doi.org/10.1161/circulationaha.106.661405
Abstract
Background— Patients with diabetes mellitus (DM) are at high risk of developing congestive heart failure (CHF). However, the relationships between glucose levels and CHF in people with or without a history of DM have not been well characterized. Methods and Results— We evaluated the associations between fasting plasma glucose and risk of hospitalization for CHF during follow-up in patients at high cardiovascular risk and without CHF enrolled in a large-scale clinical trials program. Baseline fasting plasma glucose levels were assessed in 31 546 high-risk subjects with ≥1 coronary, peripheral, or cerebrovascular disease or DM with end-organ damage who are participating in 2 ongoing parallel trials evaluating the effects of telmisartan, ramipril, or their combination (Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]; n=25 620) and the effects of telmisartan against placebo in angiotensin-converting enzyme–intolerant patients (Telmisartan Randomized Assessment Study...Keywords
This publication has 22 references indexed in Scilit:
- Apoptosis Signal-Regulating Kinase 1 Mediates Cellular Senescence Induced by High Glucose in Endothelial CellsDiabetes, 2006
- Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failureHeart, 2006
- Glucose, insulin and myocardial ischaemiaCurrent Opinion in Clinical Nutrition and Metabolic Care, 2006
- Novel Metabolic Risk Factors for Heart FailureJournal of the American College of Cardiology, 2005
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2005
- Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trialsAmerican Heart Journal, 2004
- Adaptation and Maladaptation of the Heart in Diabetes: Part IICirculation, 2002
- The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.Diabetes Care, 1999
- The effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in ratsEuropean Journal of Clinical Investigation, 1996
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974